医药中间体市场规模预计将从 2020 年的 273.567 亿美元增至 2028 年的 372.9033 亿美元。预计 2021 年至 2028 年期间,市场复合年增长率为 4.2%。
医药中间体市场已根据类型、应用、分销渠道和地区进行了分析。市场按地区分为北美、欧洲、亚太地区、中东和非洲以及南美和中美。该报告强调市场趋势、技术进步、市场动态和领先公司竞争格局分析等参数,以提供对医药中间体市场的见解和深入分析。它还包括对所有主要地区市场 COVID-19 疫情的分析。
定制研究以满足您的需求
我们可以优化和定制标准产品无法满足的分析和范围。这种灵活性将帮助您获得业务规划和决策所需的准确信息。
医药中间体市场:
复合年增长率(2020 - 2028 年)4.2%- 2020 年市场规模
273.6 亿美元 - 2028 年市场规模
372.9 亿美元
市场动态
- 財政部
- 財政部
- 財政部
- 財政部
- 財政部
- 財政部
- 財政部
- 財政部
- 財政部
关键人物;主力;重要一员
- 辉瑞公司
- 赛诺菲
- 巴斯夫
- 联化科技股份有限公司
- 迪什曼卡博根 Amcis 有限公司
- 法典
- Midas Pharma GmbH
- 奇拉康有限公司
- 德克斯特实验室有限公司
区域概况
- 北美
- 欧洲
- 亚太
- 南美洲和中美洲
- 中东和非洲
市场细分
- 良好生产规范
- 非GMP
- 抗生素
- 解热镇痛药
- 维生素
- 其他的
- 分销商
- 直销
- 北美
- 欧洲
- 亚太地区
- 中东和非洲
- 南美洲和中美洲
- 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。
市场洞察
慢性病和传染病发病率上升
医药中间体是活性药物成分 (API) 的组成部分。这些原材料在大宗药物生产过程中会经历分子变化或加工。因此,随着治疗慢性病的药物需求增加,医药中间体的需求也随之增加。根据美国疾病控制和预防中心 (CDC) 的数据,美国每 10 个成年人中就有 6 个患有至少一种慢性疾病,如癌症、心脏病、肺病、中风、神经系统疾病、糖尿病和肾病。此外,美国每 10 个成年人中就有 4 个患有两种或两种以上的慢性疾病。此外,根据欧洲慢性病联盟 (ECDA) 的新闻稿,2014 年,欧洲每 10 人中就有 9 人死于慢性疾病。因此,70-80% 的总医疗费用都花在了慢性病管理上。
传染病的流行率不断上升,尤其是在东南亚,这也可能会在未来几年推动对 API 的需求,最终推动医药中间体市场的增长。例如,根据《修订的国家结核病控制计划报告》,2018 年印度约有 44 万患者死于结核病,占全球该病导致的 150 万死亡总数的 29%。因此,慢性病和传染病的流行率如此之高,刺激了对药物的需求,最终凸显了对医药中间体的需求。
基于类型的洞察
医药中间体市场按类型分为 GMP 和非 GMP。GMP 部分在 2020 年占据了最大的市场份额,而同一部分预计在预测期内在市场上的复合年增长率最高,为 4.4%。
基于应用的洞察
医药中间体市场按用途可分为抗生素、解热镇痛药、维生素等。抗生素部分在 2020 年占据了最大的市场份额,预计在预测期内,该部分将实现 4.9% 的最高复合年增长率。
基于分销渠道的洞察
根据分销渠道,医药中间体市场细分为分销商和直销。直销部分在 2020 年占据了最大的市场份额,而分销商部分预计在预测期内将实现 4.2% 的最高复合年增长率。
在医药中间体市场运营的公司正在采用产品发布和扩张等有机战略,以扩大其全球影响力和产品组合,并满足日益增长的需求。
医药中间体市场报告范围
报告属性 | 细节 |
---|---|
2020 年市场规模 | 273.6亿美元 |
2028 年市场规模 | 372.9亿美元 |
全球复合年增长率(2020 - 2028) | 4.2% |
历史数据 | 2018-2019 |
预测期 | 2021-2028 |
涵盖的领域 | 按类型
|
覆盖地区和国家 | 北美
|
市场领导者和主要公司简介 |
|
- 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。
按类型
- 良好生产规范
- 非GMP
按应用
- 抗生素
- 解热镇痛药
- 维生素
- 其他的
按分销渠道
- 分销商
- 直销
按地理位置
北美
- 我们
- 加拿大
- 墨西哥
欧洲
- 德国
- 法国
- 意大利
- 英国
- 西班牙
- 瑞士
- 比利时
- 希腊
- 挪威
- 葡萄牙
- 瑞典
- 捷克共和国
- 克罗地亚
- 爱尔兰
- 丹麦
- 荷兰
- 俄罗斯
- 欧洲其他地区
亚太地区 (APAC)
- 中国
- 印度
- 韩国
- 日本
- 澳大利亚
- 亚太地区其他地区
中东和非洲 (MEA)
- 南非
- 沙特阿拉伯
- 阿联酋
- 火鸡
- MEA 其他地区
南美洲和中美洲(SCAM)
- 巴西
- 阿根廷
- 其余的骗局
公司简介
- 辉瑞公司
- 迪什曼集团
- 德克斯特实验室有限公司
- 赛诺菲温思罗普工业公司
- Vertellus 控股有限公司
- 巴斯夫
- 联和科技
- 法典
- Midas Pharma GmbH
- 奇拉康有限公司
- Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
- PEST and SWOT Analysis
- Market Size Value / Volume - Global, Regional, Country
- Industry and Competitive Landscape
- Excel Dataset
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The costs of the Pharmaceutical Intermediates are much higher, and they may cost US$ 5–50, or more, per kgs. The cost may also differ from product to product types.
Pharmaceutical intermediates are the raw materials used to manufacture active pharmaceutical ingredients for the final drug formulation. Pharmaceutical intermediates are used in the production of bulk drugs as well as for research and development purpose by various pharm and biopharma companies. Pharmaceutical intermediates are formed at the time of process of production or synthesis of active pharmaceutical ingredients.
Key factors that are driving the market are to rising prevalence of chronic diseases and infectious diseases, and escalating investment by pharmaceutical companies in R&D activities. However, high cost of drug manufacturing hinders the market growth.
Trends and growth analysis reports related to Life Sciences : READ MORE..
The List of Companies - Pharmaceutical Intermediate Market
- Pfizer Inc.
- Sanofi
- BASF SE
- Lianhe Chemical Technology Co., Ltd
- Dishman Carbogen Amcis Ltd
- Codexis
- Midas Pharma GmbH
- chiracon GmbH
- Dextra Laboratories Limited
- Vertellus Holdings LLC
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.